Home
NSE: ALIVUS
ISIN
NSE: ALIVUS
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) |
---|---|
05 Feb 2025 | 1226.65 |
04 Feb 2025 | 1215.4 |
03 Feb 2025 | 1175.05 |
01 Feb 2025 | 1154.6 |
31 Jan 2025 | 1202 |
30 Jan 2025 | 1168.3 |
29 Jan 2025 | 1158.4 |
28 Jan 2025 | 1156.85 |
27 Jan 2025 | 1197.35 |
24 Jan 2025 | 1151.35 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Alivus Life Sciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Net Profit of Alivus Life Sciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the oth
Read more
05 Aug 24
Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will be held o
Read more
06 Sept 24
Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 September 2024.
Read more
25 Oct 24
Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended Septembe
Read more
25 Oct 24